SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-015596
Filing Date
2022-06-22
Accepted
2022-06-22 15:58:10
Documents
15
Period of Report
2022-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20220622_8k.htm   iXBRL 8-K 38048
2 EXHIBIT 10.1 ex_389232.htm EX-10.1 49198
7 ex_389232img001.jpg GRAPHIC 27614
  Complete submission text file 0001437749-22-015596.txt   269763

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA stab-20220617.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20220617_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20220617_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20220617_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT cbli20220622_8k_htm.xml XML 2571
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 221031978
SIC: 2834 Pharmaceutical Preparations